Enanta Pharmaceuticals | Capitale Ordinario



Ordinary Share Capital Cambiamento Data
AbbVie USD 18M 0 2024-12
Amgen USD 33.58B 45M 2025-03
Arrowhead Research USD 230K 12K 2025-03
AstraZeneca USD 388M 0 2025-03
Biogen USD 100K 0 2025-03
Bristol-Myers Squibb USD 292M 0 2025-03
Gilead Sciences USD 1000K 0 2024-12
GlaxoSmithKline GBP 1.35B 1000K 2025-03
Halozyme Therapeutics USD 123K 0 2025-03
Incyte USD 193K 0 2025-03
Insmed USD 1.82M 25K 2025-03
Ionis Pharmaceuticals USD 159K 1000 2025-03
J&J USD 3.12B 0 2025-03
Ligand Pharmaceuticals USD 20K 0 2025-03
Merck USD 1.79B 0 2025-03
Neurocrine Biosciences USD 100K 0 2024-12
Novartis USD 793M 0 2024-12
Pfizer USD 481M 1000K 2025-03
PTC Therapeutics USD 78K 1000 2025-03
Roche Holding CHF 107M 0 2024-06
Sarepta Therapeutics USD 10K 0 2025-03
Vertex Pharmaceuticals USD 2.6M 0 2024-12



Enanta Pharmaceuticals Capitale Ordinario - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jul 2025.